Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Cancer Treatment Reviews · 2025-02 · 133 · 102884
DOI: 10.1016/j.ctrv.2025.102884 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-02. Verfasst von Ana Isabel Sebastião und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; Center for Neuroscience and Cell Biology, University of Coimbra (CNC-UC), Coi…. Hauptthemen laut MEDLINE: Dendritic Cells, Triple Negative Breast Neoplasms, Cancer Vaccines, Immunotherapy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Science and Technology.
Abstract (Originalsprache)
Breast cancer is the second most commonly diagnosed cancer in women and the fifth leading cause of cancer-related deaths worldwide. It is a highly heterogeneous disease, consisting of multiple subtypes that vary significantly in clinical characteristics and survival outcomes. Triple-negative breast cancer (TNBC) is a particularly aggressive and challenging subtype of breast cancer. Several immunotherapeutic approaches have been tested in patients with TNBC to improve disease outcomes, including the administration of dendritic cell (DC)-based vaccines. DCs are a heterogeneous cell population that play a crucial role in bridging the innate and adaptive immune systems. Therefore, DCs have been increasingly used in cancer vaccines due to their ability to prime and boost antigen specific T-cell immune responses. This review aims to provide a comprehensive overview of TNBC, including potential targets and pharmacological strategies, as well as an overview of DCs and their relevance in TNBC. In addition, we review ongoing clinical trials and shed light on the evolving landscape of DC-based immunotherapy for TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; Center for Neuroscience and Cell Biology, University of Coimbra (CNC-UC), Coimbra, 3004-504, Portugal; Center for Innovative Biomedicine and Biotec…
- Center for Neuroscience and Cell Biology, University of Coimbra (CNC-UC), Coimbra, 3004-504, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal; Depar…
- Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
- Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra, 3000-548 Coimbra, Portugal.
- Tecnimede Group, 2710-089 Sintra, Portugal.
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal; Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal; Coimbra Institute for Clinical and B…
Förderung
- Foundation for Science and Technology
Zitieren
APA
Sebastião, A. I., Simões, G., Oliveira, F., Mateus, D., Falcão, A., Carrascal, M. A., Gomes, C., Neves, B., & Cruz, M. T. (2025). Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications. Cancer Treatment Reviews, 133, 102884. https://doi.org/10.1016/j.ctrv.2025.102884
Vancouver
Sebastião AI, Simões G, Oliveira F, Mateus D, Falcão A, Carrascal MA, et al. Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications. Cancer Treatment Reviews. 2025;133:102884. doi:10.1016/j.ctrv.2025.102884
BibTeX
@article{Sebastio2025,
author = {Sebastião, Ana Isabel and Simões, Gonçalo and Oliveira, Filomena and Mateus, Daniela and Falcão, Amílcar and Carrascal, Mylène A and Gomes, Célia and Neves, Bruno and Cruz, Maria Teresa},
title = {Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {133},
pages = {102884},
doi = {10.1016/j.ctrv.2025.102884}
}
EUVIMED